Loading...
Expanding Dermatology Pipeline Will Unlock Future Treatment Horizons
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
47.8%7D
6.7%1Y
47.8%7D
6.7%You can edit this narrative until Jul 22 8:10 PM. Then, changes will post as Updates.
You can edit this narrative until Jul 22 8:10 PM. Then, changes will post as Updates.